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Brief Communication

Evaluation of antibiotic use in Pediatric Intensive
Care Unit of a developing country

Abstract

Qalab Abbas, Anwar Ul Haq, Raman Kumar, Syed Asad Ali, Kashif Hussain1, Sadia Shakoor

Background: Pediatric Intensive Care Unit (PICU) patients are often prescribed
antibiotics with a low threshold in comparison to patients elsewhere. Irrational antibiotics
use can lead to rapid emergence of drug resistance, so surveillance of their use is important.
Objectives: To evaluate the use of antibiotics in relation to bacteriological findings in
PICU of a Tertiary Hospital. Methods: Retrospective review of medical records of all
children (age 1 month–16 years) admitted in our closed multidisciplinary‑cardiothoracic
PICU from January to June 2013 was performed, after approval from Ethical Review
Committee. For each antibiotic, indication (prophylactic, empiric, therapeutic) and
duration of use were recorded. All diagnoses of infections were recorded according to
diagnostic criteria of IPSCC 2005. Results are presented as frequency and percentages
and median with inter quartile range using SPSS version 19. Results: All of the total
240 patients admitted in PICU during the study period received antibiotics: 43% (n = 104)
prophylactically, 42% (n = 102) empirically, and 15% (n = 15) therapeutically. Median number
of antibiotic use per patient in PICU was 3, with range of 1–7. 25% received 1 antibiotic,
23% received 2 antibiotics, 29% received 3 antibiotics, and rest received ≥4 antibiotics. Most
commonly used antibiotics were cefazolin, meropenem, vancomycin and ceftriaxone, and
most frequently used combination was meropenem and vancomycin. In majority of the
cases, (70%) empiric antibiotic combinations were stopped in 72 h. Conclusion: This is
the first report of antibiotics use in PICU from our country, which shows that antibiotics
are prescribed universally in our PICU. Strategies to assess the need for antibiotic use
are needed.
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Introduction
Children admitted to Pediatric Intensive Care
Unit (PICU) have life threatening illnesses. They either
already have infection when admitted or are at high‑risk
of acquiring infections because of different procedures,
use of invasive devices, and extended length of stay.[1]
These are the known risk factors for acquiring health
care associated infections (HAIs) which can be quite
difficult to treat but are preventable to an extent.[2] HAIs
have been reported to be in 16–23% of patients admitted
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in PICUs.[3,4] Antibiotics are the most commonly used
medicines in the Intensive Care Units (ICUs).[5] The
critical nature of the illness of patients admitted to PICU
and the high‑risk of developing HAIs often leads to
the prescription of multiple and prolonged antibiotics.
The use of antibiotics may be helpful in preventing
HAIs, but their unnecessary and irrational use has a few
serious disadvantages. Prolonged and inappropriate
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use of antibiotics has resulted in emergence of antibiotic
resistance which is an important clinical, economic,
and public health problem.[6] Several papers have been
published regarding the use of antibiotics both in adult
and pediatric critically ill patients from developed
countries.[1,2,6,7] They showed that they were able to
identify reasons for not using antibiotics in many patients.
This kind of surveillance leads to antibiotic stewardship
program and proper use. However, availability of such
data is limited from PICU of developing country specially
ours. The objective of this study is to evaluate the use
of antibiotic in relation to diagnosis and bacteriological
findings in the PICU of a tertiary hospital. This would
help in instituting strategies to prevent inappropriate use
hence improving the outcome and reduce cost.

Methods
We reviewed medical records of all children
(age ‑1 month–16 years) admitted in our closed
multidisciplinary‑cardiothoracic PICU from January to
June 2013 after Ethical Review Committee approval. Data
collected included demographic variables (age, gender),
clinical, laboratory, microbiological data, and use of
antibiotics on a structured data collection sheet. For each
patient the cumulative number of antibiotics prescribed
during the length of stay in PICU was recorded. All
diagnosis of infections was recorded according to the
diagnostic criteria of IPSCC 2005. The indications of
antibiotics were categorized as prophylaxis, empirical,
and therapeutics. Prophylactic antibiotic treatment was
defined as administration of antibiotics without any
evidence of infection to prevent infection in patients
at risk of developing infection mainly in postoperative
patients. Empiric antibiotic treatment was labeled to be
present when antibiotics were prescribed for systemic
signs of infection without identifying a specific source of
infection. Therapeutic antibiotic treatment was defined
as treatment based on culture and sensitivity report.
For each antimicrobial, the indication and duration
of antibiotics were recorded. The indication for use of
each antibiotic prescribed during the PICU stay was
documented using above criteria. Descriptive statistics
were applied using SPSS (Statistical Package for Social
Sciences) version 19. Data are present as frequency with
percentage and median with inter quartile range (IQR).

congenital heart diseases (35%), acute neurological disorders
including central nervous system infections (26.6%)
followed by respiratory problems (14.6%) [Table 2].

Antibiotics surveillance data
All patients (100%) admitted to our ICU received
antibiotics. Prophylactic therapy (three doses as per our
hospital policy) was used in 103/240 cases (43%) prior
to surgical procedures. Empirical therapy was used in
42% (101/240) while 15% (36/240) received antibiotics
therapeutically.
The median number of antibiotics received per
patient in our PICU was 3 with a range of 1–7 (IQR 2),
25% (n = 60) received one antibiotic, 23% (n = 56) received
two antibiotics, 29% (n = 70) received three antibiotics,
rest received ≥4 antibiotics in our cohort [Figure 1].
>1 antibiotic either as a combination or sequential
therapy was prescribed in 76% of the patients.
The most commonly used drugs were cefazolin,
meropenem, vancomycin, and ceftriaxone, [Figure 2].
The most frequently used combinations included
meropenem and vancomycin (24%, n = 58/240) and
meropenem, vancomycin, and colistin (12%; 28/240).
Of those who received empiric therapy, 33% of patients
received combination antibiotics. Combination therapy
with meropenem and vancomycin as prophylaxis after
surgical repair or replacement of cardiac valves was
Table 1: Basic characteristics of patients admitted in PICU
who received Antibiotics
Variable
Age in mo (median with IQR)
Duration of antibiotics
Mean±SD
Gender (male)
Source of admission
ER
Ward
OR
Outcome (expired)
Blood culture positive

During the study period, 240 patients were admitted
to PICU. Baseline characteristics of enrolled patients are
described in Table 1. The median age of our sample was
26 months with IQR of 93 and 150 (62.5%) were male. The
most common diagnostic categories were postoperative

Percent
‑
‑

150

62.5

80
60
100
22
76

33.33
25.7
41
16.9
32

PICU: Pediatric Intensive Care Unit; IQR: Inter quartile range; SD: Standard deviation

Table 2: Diagnostic categories of patients who received
antibiotics in PICU
Diagnosis

Results

No
26 (93)
10.15±7.43

Medical
Respiratory
Neurological
Cardiac/shock
Miscellaneous
Surgery/trauma
Total
PICU: Pediatric Intensive Care Unit
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Number (percentage)
136 (57)
48 (20)
44 (18.5)
22 (9)
22 (9)
104 (43)
240 (100)
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Figure 1: No of antibiotics per patient

Figure 2: Most commonly used antibiotics and their indication

prescribed to three patients. The median duration of
antibiotic use was 4 days with IQR of 2 days, and median
PICU length of stay was 4 days with IQR of 3 days. The
median duration of antibiotics use for prophylactic
therapy was 1 day with IQR of 2. The median duration
of empirical therapy was 1 day with IQR of 4 days.
The empirical therapy was deescalated after 72 h in
70% (n = 72). Failure to discontinue accounted for
15% of all cases in whom culture report was negative;
prolonged empiric treatment was continued (5–7 days)
as therapeutic in 15% (n = 15) as the culture sensitivity
report showed that organism is sensitive to the drug
prescribed empirically. Therapeutic use of antibiotics
was 15%.

therapy (2 or more drugs). These findings are concerning
since our MDRO rate, and mortality is high and all of our
patients receive antibiotics whether indicated or not. Our
study shows that empirical therapy was prescribed to the
majority (42%) of the patients without any microbiologic
evidence of infection. This might have been due to the
reason of limited microbiologic yield and the critical
condition of the patients admitted to PICU. A similar
study of antibiotic use in PICU of Canada showed
27–40% usage of empiric antibiotic treatment[2] while
another study by Ding et al. from China showed that
71% of their patients in PICU received empiric antibiotic
treatment.[1] Failure to stop empirical therapy was found
in 15% of the patients with no micro‑organisms isolated
which is similar to a study in Canada.[2]

A total of 280 blood cultures, 50 tracheal aspirates
sample, and 32 urine samples were sent for analysis
during study period and 55 micro‑organisms were
isolated from 362 specimens of 140 patients who had
one or more specimens cultured during study period.
The blood cultures were positive in 14%, and tracheal
aspirates were positive in 24%. Most common isolates
in blood were Acinetobacter, Staphylococcus and Klebsiella
pneumonia (KP). Tracheal cultures most commonly
yielded Acinetobacter and KP. Rate of MDR was 7% in our
cohort, and the most common isolates were Acinetobacter
and KP. Overall, 22/240 (9%) patients died during the
study period.

Discussion
Good antibiotics prescribing practice means using
most effective, least toxic, and least costly antibiotic for
a precise duration.[8] Our study highlights some very
important points. The entire patient population (100%)
received antibiotics as prophylaxis or empirical therapy
mostly without always having evidence of any infection
as compared to other studies that reported antibiotic
usage of 50–94% in their PICUs.[1,2,9] In our study, 76%
patients received combination or multiple antibiotics

In our study, 76% patients received more than two
antibiotics simultaneously which is much higher than
reported by Ding et al., Blinova et al. and Grohskopf et al.
[1,2,10]
They reported use of two or more antibiotics in 47%,
55–69%, and 40% of their patients, respectively. These
variations can be due to difference in prescribing practices,
differences in rates and types of infections and antibiotic
guidelines among countries but such a high rate of
combination therapy cannot be justified except in certain
conditions, like in very critical patients, with the purpose
of providing broad coverage against micro‑organisms or
when more than one organism is isolated.
Prophylaxis was given in 43% of patients for
1 day which was prescribed for the postoperative
patient, the majority (35%) of whom were postoperative
congenital heart diseases. Most common prophylactic
antibiotic prescribed was cephazolin which is the
standard prophylactic antibiotic being used in these
patient.
Another alarming finding is increased use of
carbapenems (meropenem) which was found to be the
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most commonly used drug after cephazolin, mostly
in combination with vancomycin. In contrast, other
studies by Ding et al. and Blinova et al. report use of
meropenem to be 2.5–12.5% respectively. [2,6] Other
commonly used drugs were ceftriaxone and cephazolin,
similar to other studies.[2,7] However, our use of broad
spectrum combination therapy for suspected nosocomial
infections was very high as compared to other studies.[1,2]
Several different strategies can be developed to reduce
the antibiotic use including hospital formulary
restriction, practitioners’ education and feedback
activities and teaming up with an infectious disease
specialist, microbiologist, and clinical pharmacist.[10]
Our study has the limitation of being a retrospective
review, single center study, and PRISM score was not
calculated. None the less this adds much value to the
scarce data available on antibiotic use in our country
especially in a dedicated PICU which can be used to
guide proper antibiotic use by different interventions
mentioned above.

Conclusion
This study provides valuable insight to antibiotics
usage in PICU of a developing country. Our data points
that overuse of antibiotics exists in our PICU. It is
recommended to guide antibiotics utilization according
to microbiology and discontinue empirical therapy as
soon as possible. Continued surveillance and large,
multicenter studies are recommended.
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